APA

Geis N., Zell S., Rutz R., Li W., Giese T., Mamidi S., Schultz S. & Kirschfink M. (20110519). Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. : Current cancer drug targets.

Chicago

Geis Nicolas, Zell Stefanie, Rutz Renate, Li Wenhan, Giese Thomas, Mamidi Srinivas, Schultz Stefan and Kirschfink Michael. 20110519. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. : Current cancer drug targets.

Harvard

Geis N., Zell S., Rutz R., Li W., Giese T., Mamidi S., Schultz S. and Kirschfink M. (20110519). Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. : Current cancer drug targets.

MLA

Geis Nicolas, Zell Stefanie, Rutz Renate, Li Wenhan, Giese Thomas, Mamidi Srinivas, Schultz Stefan and Kirschfink Michael. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. : Current cancer drug targets. 20110519.